Signals, Powered By EquityPandit
On Friday, the pharma major Mylan said that its subsidiary Mylan Laboratories has completed the acquisition of Famy Care.
The company said in a statement that “Mylan Laboratories has successfully completed the acquisition of certain women’s healthcare businesses, now known as Jai Pharma, which were spun off from Famy Care Ltd”.
Heather Bresch, Mylan CEO said that “In addition to strengthening our women’s healthcare offering in North America, we will continue to leverage our powerful commercial platform in Europe, now enhanced through our recent Abbott deal, to serve this important therapeutic area.”
